387
Views
10
CrossRef citations to date
0
Altmetric
Review

COPD in Biomass exposed nonsmokers: a different phenotype

&
Pages 51-58 | Received 26 Aug 2020, Accepted 08 Oct 2020, Published online: 16 Nov 2020

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease (2020 Report).
  • GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1859–1922.
  • India State-Level Disease Burden Initiative CRD Collaborators. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the global burden of disease study 1990–2016. Lancet Glob Health. 2018;6:e1363–74.
  • Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–532.
  • Jindal SK. Bidi smoking and lung diseases. In: Bidi Smoking and Public Health, Gupta PC, Asma S, editors. Ministry of health and family welfare. N. Delhi, India: Government of India, 2008:129–141.
  • Jindal SK, Aggarwal AN, Gupta D, et al. Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis. 2012;16:1270–1277.
  • Mahesh PA, Jayaraj BS, Chaya SK, et al. Variation in the prevalence of chronic bronchitis among smokers: a cross-sectional study. Int J Tuberc Lung Dis. 2014;18(7):862–869.
  • Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–743.
  • Eisner MD, Anthonisen N, Coultas D, et al. An official American thoracic society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718.
  • Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011;139(4):752–763.
  • Ozbay B, Uzun K, Arslan H, et al. Functional and radiological impairment in women highly exposed to indoor biomass fuels. Respirology. 2001;6(3):255–258.
  • Kiraz K, Kart L, Demir R, et al. Chronic pulmonary disease in rural women exposed to biomass fumes. Clin Invest Med. 2003;26(5):243–248.
  • Po JY, FitzGerald JM, Carlsten C. Respiratory disease associated with solid fuel exposure in rural women and children: systematic review and meta-analysis. Thorax. 2011;66:232–239.
  • Sana A, Somda SMA, Meda N, et al. Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis. BMJ Open Respir Res. 2018;5(1):e000246.
  • Ji W, Lim MN, Bak SH, et al. Differences in chronic obstructive pulmonary disease phenotypes between non-smokers and smokers. Clin Respir J. 2018;12(2):666–673.
  • Zhao D, Zhou Y, Jiang C, et al. Small airway disease: A different phenotype of early stage COPD associated with biomass smoke exposure. Respirology. 2018;23(2):198–205.
  • Perret JL, Abramson MJ. Biomass smoke COPD: A phenotype or a different disease? Respirology. 2018;23(2):124–125.
  • Jindal SK. Chronic obstructive pulmonary disease in non-smokers - Is it a different phenotype? Indian J Med Res. 2018;147(4):337–339.
  • CIBA Foundation Guest Symposium. Terminology, definitions and classification of chronic bronchitis, pulmonary emphysema and related conditions. Thorax. 1959;14:286–299.
  • Watson RA, Prid NB. Early history of chronic obstructive pulmonary disease 1808–1980. J Chronic Obst Pulm Dis. 2016;13(2):262–273.
  • Padmavati S, Pathak SN. Chronic cor pulmonale in Delhi: A study of 127 cases. Circulation. 1959;29:343–352.
  • Pandey MR. Domestic smoke pollution and chronic bronchitis in a rural community of the Hill region of Nepal. Thorax. 1984;39:337–339.
  • Malik SK. Profile of chronic bronchitis in North India – the PGI experience (1972–1986). Lung India. 1986;4:89–100.
  • McKay AJ, Mahesh PA, Fordham JZ, et al. Prevalence of COPD in India: a systematic review. Prim Care Respir J. 2012;21(3):313–321.
  • Ramírez-Venegas A, Sansores RH, Pérez-Padilla R, et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med. 2006;173(4):393–397.
  • Akhtar T, Ullah Z, Khan MH, et al. Chronic bronchitis in women using solid biomass fuel in rural Peshawar, Pakistan. Chest. 2007;132(5):1472–1475.
  • Pride NB. Role of infection, chronic bronchitis in non-smokers. Eur J Respir Dis. 1982;63:43–50.
  • Lundback B, Lindberg A, Lindstrom M, et al. Obstructive lung disease in Northern Sweden studies. Not 15 but 50% of smokers develop COPD? Report from the obstructive lung disease in Northern Sweden studies. Respir Med. 2003;97:115–122.
  • Mannino DM, Buist AS, Petty TL, et al. Lung function and mortality in the United States: data from the first national health and nutrition examination survey follow up study. Thorax. 2003;58:388–393.
  • Shahab L, Jarvis MJ, Britton J, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;62:1043–1047.
  • Terzikhan N, Verhamme KM, Hofman A, et al. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol. 2016;31(8):785–792.
  • Chilvers ER, Lomas DA. Diagnosing COPD in non-smokers: splitting not lumping. Thorax. 2010;65(6):465–466.
  • Schermer TR, Smeele IJ, Thoonen BP, et al. Current clinical guideline definitions of airflow obstruction and COPD over diagnosis in primary care. Eur Respir J. 2008;32:945–952.
  • Bonjour S, Adair-Rohani H, Wolf J, et al. Solid fuel use for household cooking: country and regional estimates for 1980–2010. Environ Health Perspect. 2013;121:784–790.
  • Mortimer K, Gordon SB, Jindal SK, et al. Household air pollution is a major avoidable risk-factor for cardiopulmonary disease. Chest. 2012;142:1308–1315.
  • Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2:823–860.
  • Rajagopalan S, Brook RD. The indoor-outdoor air-pollution continuum and the burden of cardiovascular disease: an opportunity for improving global health. Glob Heart. 2012;7:207–213.
  • Jindal SK, Aggarwal AN, Jindal A. Household air pollution in India and respiratory diseases: current status and future directions. Curr Opin Pulm Med. 2020;26(2):128–134.
  • Johnson P, Balakrishnan K, Ramaswamy P, et al. Prevalence of chronic obstructive pulmonary disease in rural women of Tamilnadu: implications for refining disease burden assessments attributable to household biomass combustion. Glob Health Action. 2011;4:7226.
  • Naeher LP, Michael B, Michael L, et al. Wood smoke health effects: a review. Inhal Toxicol. 2007;19:67–106.
  • Hystad P, Duong M, Brauer M, et al. Health effects of household solid fuel use: findings from 11 countries within the prospective urban and rural epidemiology study. Environ Health Perspect. 2019;127(5):57003.
  • Toledo-Pons N, Cosío BG, Velasco MD, et al. Chronic obstructive pulmonary disease in non-smokers. Arch Bronconeumol. 2017;53(2):45–46.
  • Syamlal G, Doney B, Mazurek JM. Chronic obstructive pulmonary disease prevalence among adults who have never smoked, by industry and occupation - United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2019;68(13):303–307.
  • Kotaki K, Ikeda H, Fukuda T. Trends in the prevalence of COPD in elderly individuals in an air-polluted city in Japan: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2019;14:791–798.
  • Salvi D, Limaye S, Muralidharan V, et al. Indoor particulate matter < 2.5 μm in mean aerodynamic diameter and carbon monoxide levels during the burning of mosquito coils and their association with respiratory health. Chest. 2016;149(2):459–466.
  • Krishna MT, Mahesh PA, Vedanthan P, et al. An appraisal of allergic disorders in India and an urgent call for action. World Allergy Organ J. 2020;13(7):100446.
  • Martinez FD. Early life origin of chronic obstructive pulmonary disease. New Engl J Med. 2016;375:871–878.
  • Ntritsos G, Franek J, Belbasis L, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1507–1514.
  • Behrendt CE. Mild and moderate-to-severe COPD in non-smokers: distinct demographic profiles. Chest. 2005;128(3):1239–1244.
  • Zhou Y, Wang C, Yao W, et al. COPD in Chinese non smokers. Eur Respir J. 2009;33:509–518.
  • Zhang J, Lin X, Bai C. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study. Int J Chron Obstruct Pulmon Dis. 2014;9:57–63.
  • Lee SH, Hwang ED, Lim JE, et al. The risk factors and characteristics of COPD among non smokers in Korea: an analysis of KNHANES IV and V. Lung. 2016;194:353–361.
  • Calle Rubio M, Casamor R, Miravitlles M. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD guidelines: the FENEPOC study. Int J Chron Obstruct Pulmon Dis. 2017;12:2373–2383.
  • van Gemert F, Chavannes N, Kirenga B, et al. Socio-economic factors, gender and smoking as determinants of COPD in a low-income country of sub-Saharan Africa: FRESH AIR Uganda. NPJ Prim Care Respir Med. 2016;26:16050.
  • Trigueros JA, Riesco JA, Alcázar-Navarrete B, et al. Clinical features of women with COPD: sex differences in a cross-sectional study in Spain (“The ESPIRAL-ES study”). Int J Chron Obstruct Pulmon Dis. 2019;14:2469–2478.
  • Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415.
  • Fuller-Thomson E, Chisholm RS, Brennenstuhl S. COPD in a population-based sample of never-smokers: interactions among sex, gender, and race. Int J Chronic Dis. 2016;5862026:2016.
  • Salvi SS, Brashier BB, Londhe J, et al. Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease. Respir Res. 2020;21:50.
  • Montserrat-Capdevila J, Godoy P, Marsa JR, et al. Prevalence and characteristics of chronic obstructive pulmonary disease in non-smokers. Aten Primaria. 2019;51(10):602–609.
  • Denguezli M, Daldoul H, Harrabi I, et al. COPD in nonsmokers: reports from the tunisian population-based burden of obstructive lung disease study. PLoS One. 2016;11(3):e0151981.
  • Celli BR, Halbert RJ, Nordyke RJ, et al. Airway obstruction in never smokers: results from the third national health and nutrition examination survey. Am J Med. 2005;118:1364–1372.
  • Jindal SK, Aggarwal AN, Jindal A, et al. Exacerbation rates are higher in Chronic Obstructive Pulmonary Disease in Non-smokers in India. Int J Tuber Lung Dis. 2020 (In press).
  • Tan WC, Sin DD, Bourbeau J, et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. Thorax. 2015;70:822–829.
  • Thomsen M, Nordestgaard BG, Vestbo J, et al. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. Lancet Respir Med. 2013;1(7):543–50.12.
  • Ocakli B, Acarturk E, Aksoy E, et al. The impact of exposure to biomass smoke versus cigarette smoke on inflammatory markers and pulmonary function parameters in patients with chronic respiratory failure. Inter J Chronic Obst Pulm Dis. 2018;13:1261–1267.
  • Bajpai J, Kant S, Bajaj DK, et al. Clinical, demographic and radiogical profile of smoker COPD versus non smoker COPD patients at a tertiary care center in North India. J Family Med Prim Care. 2019;8:364–368.
  • Meneghini AC, Koenigkam-Santos M, Pereira MC, et al. Biomass smoke COPD has less tomographic abnormalities but worse hypoxemia compared with tobacco COPD. Braz J Med Biol Res. 2019;52(5):e8233.
  • Echave-Sustaeta JM, Casanova LC, Cosio BG, et al. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? Int J Chron Obstruct Pulmon Dis. 2014;9:1307–1314.
  • Hong Y, Ji W, An S, et al. Sex differences of COPD phenotypes in nonsmoking patients. Int J Chron Obstruct Pulmon Dis. 2016;11:1657–1662.
  • Paulin LM, Smith BM, Koch A, et al. Occupational exposures and computed tomographic imaging characteristics in the SPIROMICS cohort. Ann Am Thorac Soc. 2018;15(12):1411–1419.
  • Lee H, Hong Y, Lim MN, et al. Inflammatory biomarkers and radiologic measurements in never-smokers with COPD: A cross-sectional study from the CODA cohort. Chron Respir Dis. 2018;15(2):138–145.
  • Barnes PJ. Small airway fibrosis in COPD. Int J Biochem Cell Biol. 2019;116:105598.
  • Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27.
  • Fernandes L, Rane S, Mandrekar S, et al. Eosinophilic airway inflammation in patients with stable biomass smoke- versus tobacco smoke-associated chronic obstructive pulmonary disease. J Health Pollut. 2019;9(24):191209.
  • Rivera RM, Cosio MG, Ghezzo H, et al. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis. 2008;12:972–977.
  • Gunbatar H, Sertogullarindan B, Ozbay B, et al. Chronic effects of environmental biomass smoke on lung histopathology in Turkish non-smoking women: A case series. Arh Hig Rada Toksikol. 2012;63:357–365.
  • Mena MA, Woll F, Cok J, et al. Histopathological lung changes in children due to biomass fuel. Am J Respir Crit Care Med. 2012;185(6):687–688.
  • Capistrano SJ, van Reyk D, Chen H, et al. Evidence of biomass smoke exposure as a causative factor for the development of COPD. Toxics. 2017;5(4):36.
  • McCarthy CE, Duffney PF, Gelein R. Dung biomass smoke activates inflammatory signaling pathways in human small airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2016;311(6):L1222–L1233.
  • Camp PG, Alejandra Ramirez-Venegas A, Sansores RH, et al. COPD phenotypes in biomass smoke-versus tobacco smoke-exposed Mexican women. Eur Respir J. 2014;43:725–734.
  • Segreti A, Stirpe E, Rogliani P, et al. Defining phenotypes in COPD: an aid to personalized healthcare. Mol Diagn Ther. 2014;18(4):381–388.
  • Le Rouzic O, Roche N, Cortot AB, et al. Defining the “Frequent exacerbator” phenotype in COPD: a hypothesis-free approach. Chest. 2018;153(5):1106–1115.
  • Maselli DJ, Hardin M, Christenson SA, et al. Clinical approach to the therapy of asthma-COPD overlap. Chest. 2019;155(1):168–177.
  • Tashkin DP, Peebles RS Jr. Controversies in allergy: is asthma chronic obstructive pulmonary disease overlap a distinct syndrome that changes treatment and patient outcomes? J Allergy Clin Immunol Pract. 2019;7(4):1142–1147.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.